aDivision of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece bDepartment of Medicine, Indiana University School of Medicine and Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, Indiana, USA.
Curr Opin Nephrol Hypertens. 2017 Nov;26(6):523-529. doi: 10.1097/MNH.0000000000000359.
In the absence of 'hard' clinical-trial evidence to define optimal blood pressure (BP) targets and validate different BP measurement techniques, management of hypertension in hemodialysis is based on expert opinions. In this review, we provide a comparative evaluation of out-of-dialysis BP monitoring versus dialysis-unit BP recordings in diagnosing hypertension, guiding its management and prognosticating mortality risk.
Owing to their high variability and poor reproducibility, predialysis and postdialysis BP recordings provide inaccurate reflection of the actual BP load outside of dialysis. Contrary to the reverse association of peridialytic BP with mortality, elevated home and ambulatory BP provides a direct mortality signal. Out-of-dialysis BP monitoring, even when done in the clinic, is a reliable approach to manage hypertension in the dialysis unit. Whenever none of these measures are available, median intradialytic SBP can provide a better estimate of interdialytic BP levels compared with peridialytic BP measurements.
Although out-of-dialysis BP monitoring have better diagnostic accuracy and prognostic validity, randomized trials are needed to ascertain BP targets for managing hypertension in hemodialysis patients.
由于缺乏“硬”临床试验证据来定义最佳血压(BP)目标和验证不同的 BP 测量技术,因此血液透析中的高血压管理基于专家意见。在这篇综述中,我们对透析外 BP 监测与透析单元 BP 记录在诊断高血压、指导其管理和预测死亡率风险方面进行了比较评估。
由于透析前和透析后 BP 记录的变异性高且重现性差,因此它们不能准确反映透析外的实际 BP 负荷。与透析期间 BP 与死亡率的反向关联相反,升高的家庭和动态 BP 提供了直接的死亡信号。即使在诊所进行透析外 BP 监测,也是管理透析单元中高血压的可靠方法。如果这些措施都不可用,则与透析期间 BP 测量相比,中位透析内 SBP 可以更好地估计透析间 BP 水平。
尽管透析外 BP 监测具有更好的诊断准确性和预后价值,但仍需要随机试验来确定管理血液透析患者高血压的 BP 目标。